Market Overview
On Thursday, U.S. equity markets closed lower, with the S&P 500 slipping 0.4% to 7,545.96 points, the Nasdaq Composite dropping 1% to 26,017.95 points, and the Dow Jones Industrial Average edging down 0.1% to 52,609.83 points. The technology sector led the declines, while the healthcare segment rose about 2%.
Taiwan Semiconductor Manufacturing (TSMC) Results
TSMC announced a 77% year‑over‑year increase in quarterly net profit, reaching T$706.6 billion (approximately $22 billion), comfortably beating consensus estimates. Despite the earnings beat, the company’s U.S.-listed shares fell 3.1% after market close. Management signaled that strong AI‑related demand could persist through the end of the decade. Crucially, TSMC lifted its 2026 capital‑expenditure guidance to a range of $60 billion‑$64 billion and disclosed an additional $100 billion investment in Arizona, expanding its U.S. manufacturing footprint.
Analyst Commentary on TSMC
Dan Coatsworth, head of markets at AJ Bell, noted that the muted market reaction likely reflects the more than doubling of TSMC’s share price over the past 12 months and concerns that expanding outside Taiwan, particularly in the United States, could pressure margins. He added that while capacity expansion is justified by a supply‑demand gap, investors will watch for disciplined spending.
Upcoming Technology Earnings
The article highlighted that the next wave of earnings will include major chipmakers and “Magnificent Seven” firms such as Alphabet, Intel, IBM, Texas Instruments, Tesla, Microsoft, Meta, Amazon, Arm, Qualcomm and Apple. Capital‑spending plans of these companies will be scrutinized for AI build‑out implications, and market participants expect continued muted stock reactions even to strong results.
Netflix Outlook
Netflix is scheduled to report earnings after the market close on Thursday. Analysts cautioned that the streaming giant may not deliver a “blowout” quarter, pointing to modest hit‑driven viewership and ongoing competition. The company’s nascent advertising business remains a focal point for investors.
Healthcare Movers
UnitedHealth Group posted earnings that far exceeded expectations, with its medical cost ratio improving dramatically, driving the stock up 3.6% and helping the S&P 500 healthcare sector gain 2%. Abbott Laboratories surged 10.3%, delivering top‑ and bottom‑line guidance that beat estimates and indicating a return to double‑digit growth in continuous glucose monitoring (CGM) sales.
U.S. Economic Data
Retail sales for June rose 0.2% month‑on‑month to $768.6 billion, matching forecasts but slowing from May’s revised 1.0% gain; gasoline station sales fell 5.3% to $60.6 billion amid lower oil prices. Initial jobless claims dropped to 208,000, below the consensus estimate of 216,000, suggesting continued labor‑market resilience. Analysts said the data support an upgrade to second‑quarter real‑GDP tracking estimates and underline the strength of consumer spending.
Monetary Policy Implications
Earlier in the week, softer U.S. CPI and PPI numbers had reduced expectations for a July Fed rate hike. The CME FedWatch tool now shows roughly a 12% probability of a 25‑basis‑point increase at the July 28‑29 meeting, down from about 25% a week earlier.
Geopolitical and Commodity Context
Escalating tensions between the United States and Iran have pushed Brent crude futures up more than 11% this week, contributing to a double‑digit rise in oil prices. The conflict follows Iranian attacks on commercial tankers in the Strait of Hormuz and subsequent U.S. strikes.